Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 328 entries
View as:

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01535066 Org: User:
Start: 05/16/12 End: 07/01/18 Due: 07/01/19

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01224665 Org: User:
Start: 11/25/11 End: 05/31/24 Due: 05/31/25

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003784 Org: User:
Start: 05/31/99 End: - Due: -

S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00041132 Org: User:
Start: 09/30/02 End: 06/30/11 Due: 06/30/12

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06116682 Org: User:
Start: 11/19/24 End: 05/31/28 Due: 05/31/29

S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00121186 Org: User:
Start: 07/31/05 End: 12/31/11 Due: 12/31/12

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00822120 Org: User:
Start: 07/31/09 End: 06/30/22 Due: 06/30/23

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01959139 Org: User:
Start: 01/23/14 End: 11/09/23 Due: 11/09/24

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03939481 Org: User:
Start: 05/14/19 End: 02/28/26 Due: 02/28/27

S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT

Phase: N/A Priority: Normal
NCT ID: NCT00288106 Org: User:
Start: 09/30/05 End: 05/31/09 Due: 05/31/10

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Phase: N/A Priority: Normal
NCT ID: NCT00301886 Org: User:
Start: 05/31/06 End: 05/31/06 Due: 05/31/07

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Phase: N/A Priority: Normal
NCT ID: NCT00003223 Org: User:
Start: 12/31/97 End: 03/31/00 Due: 03/31/01

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00004031 Org: User:
Start: 07/31/97 End: 10/31/13 Due: 10/31/14

S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo

Phase: N/A Priority: Normal
NCT ID: NCT00382018 Org: User:
Start: 10/31/06 End: 07/11/17 Due: 07/11/18

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02785939 Org: User:
Start: 09/30/14 End: 06/30/19 Due: 06/30/20

S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach

Phase: N/A Priority: Normal
NCT ID: NCT00004233 Org: User:
Start: 02/28/01 End: 01/31/07 Due: 01/31/08

Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT02766335 Org: User:
Start: 07/31/14 End: 09/30/20 Due: 09/30/21

S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin

Phase: N/A Priority: Normal
NCT ID: NCT01120262 Org: User:
Start: 02/28/10 End: 07/31/10 Due: 07/31/11

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00856492 Org: User:
Start: 04/30/10 End: 12/31/15 Due: 12/31/16

Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04173507 Org: User:
Start: 02/14/20 End: 05/01/24 Due: 05/01/25

S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00084435 Org: User:
Start: 07/31/05 End: 01/31/07 Due: 01/31/08

SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002651 Org: User:
Start: 05/31/95 End: 06/30/13 Due: 06/30/14

S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00085501 Org: User:
Start: 07/31/04 End: 07/31/11 Due: 07/31/12

S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

Phase: N/A Priority: Normal
NCT ID: NCT00003590 Org: User:
Start: 11/30/98 End: 07/31/11 Due: 07/31/12

S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00045162 Org: User:
Start: 11/30/02 End: 12/31/09 Due: 12/31/10